High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7.
Xiuli JinWeixin FuDan LiNingning WangJiayu ChenZilu ZengJiaqi GuoHao LiuXinping ZhongHu PengXin YuJing SunXinhe ZhangXue WangBeibei XuYingbo LinJianping LiuClaudia KutterYiling LiPublished in: OncoTargets and therapy (2021)
Taken together, the abnormal high expression of LINC01268 is associated with HCC progression via regulating MAP3K7, suggesting LINC01268 as a novel marker for HCC prognosis and potentially a new therapeutic target.